Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hypogonadism

• Kisspeptin Administration Subcutaneously to Patients With IHH
• Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
• Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
• An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
• Natesto Spermatogenesis Reboot
• Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
• Testosterone Treatment in Men With Chronic Kidney Disease
• A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial
• Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
• A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel
• Opioid Antagonism in Hypogonadotropic Hypogonadism
• Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
• Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
• Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
• The Effects of Natesto For Treatment Of Hypogonadism
• A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845
• Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
• Vogelxo(R) ABPM Study in Hypogandal Men
• Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen
• Testopel ® vs. Generic Testosterone Pellets.
• Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality
• Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men
• Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
• A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
• A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
• A Study to Evaluate Androderm's Effect on Blood Pressure in Adult Hypogonodal Male Participants.
• Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
• A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
• Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
• Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
• Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
• Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function
• Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
• Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
• Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Obese Men With T2DM and Hypogonadism
• Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)
• Testosterone in Bariatric Patients
• Efficacy of Testosterone Gel to Restore Normal Serum Values of Testosterone During the Acute Phase of Critical Illness in Adult ICU Patients
• Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
• Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
• A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men
• Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism
• Extragonadal Effects of hCG on Calcium Homeostasis
• Evaluation of Testosterone Nasal Gel in Hypogonadal Boys
• A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
• Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.
• Hypogonadotropic Hypogonadism in Obese Young Males
• Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).
• Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)
• Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters
• Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
• Periodontal Profile of Hypogonadic Men
• Subcutaneous vs. Intramuscular Testosterone
• Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)
• Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism
• Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)
• Administration of Kisspeptin in Patients With Hyperprolactinemia
• Kisspeptin Influence on Glucose Homeostasis
• Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™
• The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate
• A 6 Month Safety Extension Study of MBGS205
• Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism
• Pubertal Induction in Individuals With Hypogonadism
• Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction
• Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism
• Cardiovascular Outcomes of Low Testosterone
• Product Transference Study of Testagen™ TDS®-Testosterone
• Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
• Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism
• A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
• Testosterone Replacement in Renal Failure
• Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
• Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
• Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome
• Phlebotomy Study of Testosterone Undecanoate
• Reprometabolic Syndrome Mediates Subfertility in Obesity
• A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene
• Testosterone, Metformin, or Both, for Hypogonadism in Obese Males
• Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY)
• Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men
• Testosterone Therapy in Hypogonadal Men Treated With Opioids
• Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors
• Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism
• A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism
• Lifestyle Intervention and Testosterone Replacement in Obese Seniors
• TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST
• Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism
• An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
• Testosterone Plus Finasteride Treatment After Spinal Cord Injury
• Pharmacokinetic Study of Testosterone
• Oral Testosterone for the Treatment of Hypogonadism in Males
• Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy
• Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
• Effect of Intranasal Insulin on LH Concentrations in Man
• A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
• ITT-5 Mechanisms of Spermatogenesis in Man
• Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism
• Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism
• The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism
• Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment
• Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions
• MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
• An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
• Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
• The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism
• A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel
• A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel
• LutrePulse Hypogonadotropic Hypogonadism
• Neuropeptides in Human Reproduction
• Androgen Regulation of Priapism in Sickle Cell Disease
• Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
• Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function
• Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)
• Clomid in Men With Low Testosterone With and Without Prior Treatment
• A Dose Ranging Study to Examine Testagen® TDS-Testosterone 5%
• The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel
• Pharmacokinetic Study of Testosterone Enanthate
• Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration
• Testosterone Replacement for Male Opioid Agonist Maintained Patients
• A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy
• Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism
• Safety and Efficacy Trial of Testosterone Undecanoate
• Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism
• Testosterone Undecanoate and Quality of Life of Men and Spouses
• Vitamin D Treatment and Hypogonadism in Men
• Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism
• An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
• Oral Testosterone for the Treatment of Hypogonadism
• A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)
• A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
• Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
• Testosterone and Pain Sensitivity
• A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel
• Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP
• Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
• Effects of Medications in Patients With Hypogonadism
• Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)
• Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
• The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism
• Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism
• Testosterone and Alendronate in Hypogonadal Men
• The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups
• Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
• Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
• Kisspeptin in the Evaluation of Delayed Puberty
• A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
• Sequential Therapy for Hypogonadotropic Hypogonadism
• Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
• The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
• A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
• CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy
• Testosterone Therapy in Heart Failure
• Efficacy, Pharmacokinetics and Safety of Testosterone
• Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
• Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
• Efficacy of an Intranasal Testosterone Product
• Time to Eugonadal Range, Time to Steady State and Drying Time
• Androgen for Leydig Cell Proliferation
• Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men
• Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
• Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism
• Hypogonadism in Young Men With Type 2 Diabetes
• ESPRIT Study in Hypogonadal Men
• Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males
• Testosterone Replacement in Men With Diabetes and Obesity
• Testosterone Replacement in Metabolic Syndrome and Inflammation
• Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism
• Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men
• NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)
• Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
• A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism
• Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism
• Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy
• Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure
• Efficacy and Tolerability of an Intra-Nasal Testosterone Product
• Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism
• Cycled Testosterone Replacement Study
• Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
• Administration of Kisspeptin to Subjects With Reproductive Disorders
• Pharmacokinetic Study to Determine Time to Steady-state
• A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations
• A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations
• To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion
• Testosterone for Penile Rehabilitation After Radical Prostatectomy
• Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients
• Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis
• Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
• Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
• Androgen Deprivation Therapy Study
• Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks
• To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
• Influence of Administration Route of Testosterone on Male Fertility
• A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations
• Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
• Clomiphene in Males With Prolactinomas and Persistent Hypogonadism
• The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men
• Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men
• ORAL T-6: Oral Androgens in Man-6
• NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers
• Reandron in Diabetic Men Witn Low Testosterone Level
• Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism
• Study of 3 Doses of ARD-0403 in Testosterone Deficient Men
• Open-Label Study of ARD-0403 in Testosterone Deficient Men
• A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone
• Testosterone for Peripheral Vascular Disease
• Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
• Effect of Testosterone Replacement on Insulin Resistance
• 5-Alpha Reductase and Anabolic Effects of Testosterone
• Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men
• Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism
• Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
• Safety of Testosterone Undecanoate i.m. in Hypogonadal Men
• Open-Label Study of ARD-0403 in Testosterone Deficient Men
• Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes
• Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)
• Testosterone Treatment for Hypogonadal Men
• Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
• Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR
• The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction
• Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
• Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice
• Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
• 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men
• Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.
• Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone
• Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
• Investigating the Regulation of Reproductive Hormones in Adult Men
• Pulsatile GnRH in Anovulatory Infertility
• Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
• Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men
• Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception
• Letrozole Treatment in Normal and GnRH Deficient Women
• Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
• Testosterone for Men With Insulin Treated Type 2 Diabetes
• Exercise and Testosterone Therapy in Elderly Men With Physical Frailty
• Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])
• Does Testosterone Improve Function in Hypogonadal Older Men
• A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
• Testosterone Replacement in Older Men and Atherosclerosis Progression
• Testosterone Replacement Therapy in Chronic Spinal Cord Injury
• A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)
• Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
• TOM: Testosterone in Older Men With Sarcopenia
• Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
• Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism
• Three-Year Trial on a New Testosterone Gel
• The Effect of Testosterone on Mood and Quality of Life
• TRADE-Testosterone Replacement and Dutasteride Effectiveness
• Pharmacokinetic Evaluation of Testosterone Gel (1%)
• Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
• Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
• Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
• The Effects of Testosterone on Prostate Tissue (ACYP-1)
• Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
• Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes
• Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
• Short-term Effects of Aromatase Inhibition in Obese Men
• Anastrozole Administration in Elderly Hypogonadal Men
• Older Men and Testosterone
• Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
• Testosterone and Growth Hormone for Bone Loss in Men
• Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism
• Prevention of Osteoporosis in Men With Prostate Cancer
• Leuprolide in Treating Adults With Hypogonadotropism
• Leuprolide in Determining the Cause of Gonadotropin Deficiency